CoChat

Infective endocarditis in intravenous drug abusers

Miró, José M., Moreno, Asuncion, Mestres, Carlos A. · 2003 · Current Infectious Disease Reports

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Infective endocarditis (IE) is one of the most severe complications in intravenous drug abusers (IVDA). IE usually involves the tricuspid valve, Staphylococcus aureus is the most common etiologic agent, and it has a relatively good prognosis. Currently, between 40% and 90% of IVDA with IE are HIV infected, and the HIV epidemic has caused a decrease in the incidence of this disease, probably due to changes in drug administration habits undertaken by addicts in order to avoid HIV transmission. This review focuses on progress made over the past few years in some aspects of IE in IVDA. The pathogenesis of tricuspid endocarditis is still unknown more than 60 years after the first series. The most important advance in antibiotic therapy is that noncomplicated S. aureus right-sided endocarditis can be successfully treated with an intravenous 2-week course of nafcillin or cloxacillin plus an aminoglycoside, although probably the aminoglycoside administration could be stopped after the first 3 to 5 days. Surgery in HIV-infected IVDA with IE does not worsen the prognosis. Considering the possibility of reinfection in IVDA, prosthetic material is usually avoided. Tricuspid valvulectomy or valve repair should be considered the technique of choice in IVDA with right-sided IE. Replacement of the tricuspid valve by a cryopreserved mitral homograft is the latest introduction into clinical practice. It provides atrioventricular competence, thereby avoiding late right heart failure. Reinfections can be treated medically with a negligible reoperation rate. Overall mortality for HIV-infected or non-HIV-infected IVDA with IE is similar. However, among HIV-infected IVDA, mortality is significantly higher in those who are most severely immunosuppressed, with CD4(+) cell counts below 200/L or with AIDS criteria.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11908-003-0007-9

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 102 references

Research works printed but not linked: 8

  1. Sheagren JN:Endocarditis complicating parenteral drug abuse. In Current Cinical Topics in Infectious Diseases. Edited by Remington JS, Swartz MN. New York: McGraw-Hill;1981:211–233.
  2. Martin-Davila P, Fortun J, Navas E, et al.: Analysis of mortality and risk factors associated in native valve endocarditis in drug users: the importance of vegetation size [abstract: L-762]. In 42nd Interscience Conference on Antimcrobial Agents and Chemotherapy (ICAAC) Abstracts, American Society for Microbiology. San Diego: September 27–30, 2002.
  3. Torres-Tortosa M, González M, Pérez E, et al.: Endocarditis infecciosa en heroinónamos en la provincia de Cádiz. Un estudio multicéntrico sobre 150 episodios. Med Clin (Barc) 1992, 98:521–526.
  4. De Rosa A, Botvinik G, Kaufman S, Rigou D: Endocarditis infecciosa y drogadicción. Medicina (Buenos Aires) 1994, 54:193–198.
  5. Cannon NJ, Cobbs CG: Infective endocarditis in drug addicts. In Infective Endocarditis. Edited by Kaye D. Baltimore: University Park Press; 1976:111–127.
  6. Paone G, Silverman NA: Cardiac surgery in patients with HIV disease. In Advanced Techniques in Cardiac Surgery. Edited by Franco KL, Verrier ED. New York: BC Decker; 1999:20–24. This chapter analyzes the short-and long-term prognosis of 108 HIV-infected patients who underwent cardiac surgery (1989-1997). Drug abuse was the etiologic factor in 76% of cases. Indications of surgery were IE in 84 patients, other valve diseases in 14, coronary artery disease in seven, and other in three patients.
  7. Sons H, Dausch W, Kuh JH: Tricuspid valve repair in rightsided endocarditis. J Heart Val Dis 1997, 6:636–641.
  8. Miyagishima RT, Brumwell ML, Jamieson WRE, Munt BI: Tricuspid valve replacement using a cryopreserved mitral homograft. J Heart Val Dis 2000, 9:805–808.

Cited by

See all 68

Metadata

Authors
Miró, J. M., Moreno, A., & Mestres, C. A.
Affiliations
  • Hospital Clínic de Barcelona (ES)
  • Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Venue
Current Infectious Disease Reports
Published
2003-07
Volume
5
Issue
4
Pages
307-316
ISSN
  • 1523-3847 (ISSN-L)
  • 1534-3146
OpenAlex
W2029847539
Cited by
68
References
102
Citations by year
2026: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 2 · 2012: 1
FWCI
1.88
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Current Infectious Disease Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
infective endocarditis, intravenous drug use, tricuspid valve, Staphylococcus aureus, HIV infection, right-sided endocarditis, antibiotic therapy, nafcillin, cloxacillin, aminoglycosides, tricuspid valvuloplasty, tricuspid valve replacement, reinfection, mortality, immunosuppression, CD4 count

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Infective endocarditis in intravenous drug abusers. https://app.cochat.ai/papers/10.1007/s11908-003-0007-9
The paper
Miró, J. M., Moreno, A., & Mestres, C. A. (2003). Infective endocarditis in intravenous drug abusers. Current Infectious Disease Reports. https://doi.org/10.1007/s11908-003-0007-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.